The global Chimeric Antigen Receptor (CAR) T-Cell Therapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
CD19-targeted Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chimeric Antigen Receptor (CAR) T-Cell Therapy include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics and Sorrento Therapeutics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor (CAR) T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor (CAR) T-Cell Therapy. This report contains market size and forecasts of Chimeric Antigen Receptor (CAR) T-Cell Therapy in global, including the following market information:
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Chimeric Antigen Receptor (CAR) T-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment Percentages, by Type, 2023 (%)
CD19-targeted
BCMA-targeted
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment Percentages, by Application, 2023 (%)
Lymphoma
Multiple Myeloma
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chimeric Antigen Receptor (CAR) T-Cell Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Chimeric Antigen Receptor (CAR) T-Cell Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chimeric Antigen Receptor (CAR) T-Cell Therapy, market overview.
Chapter 2: Global Chimeric Antigen Receptor (CAR) T-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chimeric Antigen Receptor (CAR) T-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Overall Market Size
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size: 2023 VS 2030
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size Markets, 2023 & 2030
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2024
4.2.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2025-2030
4.2.3 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2023 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2024
5.2.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2025-2030
5.2.3 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2023 & 2030
6.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2024
6.2.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2025-2030
6.2.3 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.3.2 US Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.4.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.3 France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.4 U.K. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.5 Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.4.8 Benelux Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.5.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.6.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.6.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030
6.7.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
6.7.5 UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size, 2019-2030
7 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.1.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.2.4 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.4.4 J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.5.4 JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.6.4 FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Company Summary
7.7.2 CARsgen Therapeutics Business Overview
7.7.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.7.4 CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.7.5 CARsgen Therapeutics Key News & Latest Developments
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Company Summary
7.8.2 Autolus Therapeutics Business Overview
7.8.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.8.4 Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.8.5 Autolus Therapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Company Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Mustang Bio
7.10.1 Mustang Bio Company Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.10.4 Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.10.5 Mustang Bio Key News & Latest Developments
7.11 Bluebird Bio
7.11.1 Bluebird Bio Company Summary
7.11.2 Bluebird Bio Business Overview
7.11.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.11.4 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.11.5 Bluebird Bio Key News & Latest Developments
7.12 Cellectis
7.12.1 Cellectis Company Summary
7.12.2 Cellectis Business Overview
7.12.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.12.4 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.12.5 Cellectis Key News & Latest Developments
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Company Summary
7.13.2 Allogene Therapeutics Business Overview
7.13.3 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.13.4 Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.13.5 Allogene Therapeutics Key News & Latest Developments
7.14 Celyad
7.14.1 Celyad Company Summary
7.14.2 Celyad Business Overview
7.14.3 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Major Product Offerings
7.14.4 Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global Market (2019-2024)
7.14.5 Celyad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers in Global Market
Table 3. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Global Market
Table 5. Top Chimeric Antigen Receptor (CAR) T-Cell Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Type
Table 9. List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Company Summary
Table 31. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 32. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 36. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 40. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 44. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 48. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 52. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. FOSUNKite Key News & Latest Developments
Table 54. CARsgen Therapeutics Company Summary
Table 55. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 56. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. CARsgen Therapeutics Key News & Latest Developments
Table 58. Autolus Therapeutics Company Summary
Table 59. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 60. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Autolus Therapeutics Key News & Latest Developments
Table 62. Sorrento Therapeutics Company Summary
Table 63. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 64. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Sorrento Therapeutics Key News & Latest Developments
Table 66. Mustang Bio Company Summary
Table 67. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 68. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. Mustang Bio Key News & Latest Developments
Table 70. Bluebird Bio Company Summary
Table 71. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 72. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Bluebird Bio Key News & Latest Developments
Table 74. Cellectis Company Summary
Table 75. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 76. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. Cellectis Key News & Latest Developments
Table 78. Allogene Therapeutics Company Summary
Table 79. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 80. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Allogene Therapeutics Key News & Latest Developments
Table 82. Celyad Company Summary
Table 83. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Offerings
Table 84. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. Celyad Key News & Latest Developments
List of Figures
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Therapy Segment by Type in 2023
Figure 2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Segment by Application in 2023
Figure 3. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue in 2023
Figure 8. By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 16. US Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 28. China Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Novartis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bristol-Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. J & J Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. JW Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. FOSUNKite Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. CARsgen Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Autolus Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Mustang Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Allogene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Celyad Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
